BR0207527A - Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso - Google Patents
Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infecciosoInfo
- Publication number
- BR0207527A BR0207527A BR0207527-0A BR0207527A BR0207527A BR 0207527 A BR0207527 A BR 0207527A BR 0207527 A BR0207527 A BR 0207527A BR 0207527 A BR0207527 A BR 0207527A
- Authority
- BR
- Brazil
- Prior art keywords
- producing
- cell culture
- virus
- composition
- reovirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12251—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
"MéTODO PARA PRODUZIR VìRUS DE UMA CULTURA DE CELULAS, COMPOSIçãO, E, MéTODO PARA PRODUZIR REOVìRUS INFECCIOSO". A presente invenção é dirigida a um método de extrair vírus, particularmente reovírus, a partir de uma cultura de células. O vírus infeccioso pode ser extraido a partir da cultura com um detergente em uma temperatura conveniente, tal como 25<198>C ou 37<198>C, para produzir elevados títulos de vírus. Detergentes tanto iónicos como não-iónicos podem ser usados na presente invenção.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27673401P | 2001-03-16 | 2001-03-16 | |
| PCT/CA2002/000331 WO2002074940A1 (en) | 2001-03-16 | 2002-03-11 | Method of extracting virus from cell culture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0207527A true BR0207527A (pt) | 2004-02-25 |
Family
ID=29420186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0207527-0A BR0207527A (pt) | 2001-03-16 | 2002-03-11 | Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6808916B2 (pt) |
| EP (2) | EP1370643A1 (pt) |
| JP (2) | JP4087712B2 (pt) |
| AR (1) | AR034216A1 (pt) |
| BR (1) | BR0207527A (pt) |
| CA (1) | CA2437962C (pt) |
| DK (1) | DK2253701T3 (pt) |
| ES (1) | ES2500645T3 (pt) |
| HK (1) | HK1150859A1 (pt) |
| IL (2) | IL157304A0 (pt) |
| MX (1) | MXPA03007535A (pt) |
| NZ (1) | NZ527525A (pt) |
| WO (1) | WO2002074940A1 (pt) |
| ZA (1) | ZA200306228B (pt) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1501921T4 (da) | 2002-04-30 | 2012-10-08 | Oncolytics Biotech Inc | Forbedrede virusrensningsmetoder |
| EP1634947A4 (en) * | 2003-06-10 | 2007-10-03 | Shimadzu Corp | EXTRACT FROM A CULTURED MAMMALIAN CELL, PROCESS FOR THEIR PREPARATION AND METHOD FOR CELL-FREE PROTEIN SYNTHESIS USING THE EXTRACT |
| US7901921B2 (en) | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
| US10260049B2 (en) | 2005-08-01 | 2019-04-16 | Virocure, Inc. | Attenuated reovirus |
| US10668119B2 (en) | 2005-08-01 | 2020-06-02 | Virocure, Inc. | Attenuated reovirus |
| EP2952583A1 (en) | 2007-03-12 | 2015-12-09 | Oncolytics Biotech Inc. | Reoviruses having modified sequences |
| US10369171B2 (en) | 2007-03-13 | 2019-08-06 | Virocure, Inc. | Attenuated reoviruses for selection of cell populations |
| AR066649A1 (es) * | 2007-05-21 | 2009-09-02 | Oncolytics Biotech Inc | Reovirus mutantes y metodos de elaboracion y uso de los mismos |
| EP2211880A4 (en) * | 2007-10-22 | 2012-11-14 | Oncolytics Biotech Inc | TREATMENT PROCEDURE FOR PROLIFERATIVE DISEASES |
| CN201163385Y (zh) * | 2008-01-15 | 2008-12-10 | 昆山渝榕电子有限公司 | 笔记本电脑及其脚垫 |
| JP2011520994A (ja) * | 2008-05-27 | 2011-07-21 | オンコリティクス バイオテク，インコーポレーテッド | 腫瘍崩解性レオウイルス療法中の炎症性サイトカイン産生の排除 |
| MX339014B (es) * | 2008-05-27 | 2016-05-09 | Oncolytics Biotech Inc | Modulacion de presion intersticial y suministro y distribucion viral oncolitica. |
| WO2012075376A2 (en) | 2010-12-02 | 2012-06-07 | Oncolytics Biotech Inc. | Lyophilized viral formulations |
| SG190418A1 (en) | 2010-12-02 | 2013-07-31 | Oncolytics Biotech Inc | Liquid viral formulations |
| CA2832367A1 (en) | 2011-04-29 | 2012-11-01 | Oncolytics Biotech Inc. | Methods of purifying viruses using gel permeation chromatography |
| KR102186997B1 (ko) * | 2013-03-15 | 2020-12-07 | 안선 바이오파르마, 아이엔씨. | 단백질 정제의 신규한 방법 |
| EP3068411B1 (en) | 2013-11-15 | 2020-03-18 | Oncolytics Biotech Inc. | Oncolytic viruses and increased cancer treatment regimens |
| US10280199B2 (en) | 2014-02-07 | 2019-05-07 | Phibro Animal Health Corporation | Coronavirus proteins and antigens |
| WO2016130569A1 (en) * | 2015-02-09 | 2016-08-18 | Mj Biologics, Inc. | A composition comprising pedv antigens and methods for making and using the composition |
| DK3172317T3 (da) * | 2014-07-24 | 2019-07-22 | Janssen Vaccines & Prevention Bv | Fremgangsmåde til oprensning af poliovirus fra cellekulturer |
| GB201417042D0 (en) * | 2014-09-29 | 2014-11-12 | Fkd Therapies Oy | Method |
| WO2023277173A1 (ja) * | 2021-06-30 | 2023-01-05 | 旭化成メディカル株式会社 | ウイルスの回収方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| JPS6344532A (ja) | 1986-08-11 | 1988-02-25 | Biseibutsu Kagaku Kenkyusho:Kk | 豚のレオウイルス感染症ワクチン |
| US5614413A (en) * | 1993-07-01 | 1997-03-25 | The Uab Research Foundation | Encapsidated recombinant poliovirus nucleic acid and methods of making and using same |
| HRP950097A2 (en) * | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
| US6146873A (en) * | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| EP0968284B1 (en) * | 1996-11-20 | 2006-12-13 | Introgen Therapeutics, Inc. | An improved method for the production and purification of adenoviral vectors |
| US6214333B1 (en) * | 1997-07-08 | 2001-04-10 | Texas Heart Institute | Vasoprotective recombinant adenovirus vector containing a human TFPI gene |
| US6110461A (en) | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
| TWI289158B (en) | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
-
2002
- 2002-03-11 CA CA002437962A patent/CA2437962C/en not_active Expired - Lifetime
- 2002-03-11 EP EP02708064A patent/EP1370643A1/en not_active Withdrawn
- 2002-03-11 IL IL15730402A patent/IL157304A0/xx unknown
- 2002-03-11 WO PCT/CA2002/000331 patent/WO2002074940A1/en active IP Right Grant
- 2002-03-11 EP EP10171853.4A patent/EP2253701B1/en not_active Expired - Lifetime
- 2002-03-11 BR BR0207527-0A patent/BR0207527A/pt not_active IP Right Cessation
- 2002-03-11 ES ES10171853.4T patent/ES2500645T3/es not_active Expired - Lifetime
- 2002-03-11 DK DK10171853.4T patent/DK2253701T3/da active
- 2002-03-11 JP JP2002574332A patent/JP4087712B2/ja not_active Expired - Lifetime
- 2002-03-11 NZ NZ527525A patent/NZ527525A/en unknown
- 2002-03-11 MX MXPA03007535A patent/MXPA03007535A/es active IP Right Grant
- 2002-03-14 US US10/097,183 patent/US6808916B2/en not_active Expired - Lifetime
- 2002-03-14 AR ARP020100923A patent/AR034216A1/es unknown
-
2003
- 2003-08-07 IL IL157304A patent/IL157304A/en active IP Right Grant
- 2003-08-12 ZA ZA200306228A patent/ZA200306228B/en unknown
-
2004
- 2004-06-10 HK HK11104931.1A patent/HK1150859A1/xx not_active IP Right Cessation
- 2004-08-10 US US10/916,378 patent/US7186542B2/en not_active Expired - Lifetime
-
2007
- 2007-08-15 JP JP2007211995A patent/JP2007295937A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1370643A1 (en) | 2003-12-17 |
| ES2500645T3 (es) | 2014-09-30 |
| US6808916B2 (en) | 2004-10-26 |
| EP2253701B1 (en) | 2014-08-13 |
| EP2253701A1 (en) | 2010-11-24 |
| US20050095692A1 (en) | 2005-05-05 |
| CA2437962A1 (en) | 2002-09-26 |
| WO2002074940A1 (en) | 2002-09-26 |
| AR034216A1 (es) | 2004-02-04 |
| HK1150859A1 (en) | 2012-01-13 |
| JP2007295937A (ja) | 2007-11-15 |
| JP4087712B2 (ja) | 2008-05-21 |
| IL157304A (en) | 2010-04-29 |
| ZA200306228B (en) | 2004-08-12 |
| NZ527525A (en) | 2005-03-24 |
| US7186542B2 (en) | 2007-03-06 |
| JP2004520841A (ja) | 2004-07-15 |
| CA2437962C (en) | 2005-11-15 |
| DK2253701T3 (da) | 2014-10-20 |
| US20020168764A1 (en) | 2002-11-14 |
| MXPA03007535A (es) | 2003-12-11 |
| IL157304A0 (en) | 2004-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0207527A (pt) | Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso | |
| BR0309659A (pt) | Método para produzir vìrus de uma cultura de células, composição, e, método para produzir reovìrus infeccioso | |
| BRPI0516221A (pt) | método de produção de vìrus de uma cultura de células, composição, e, método de produção de reovìrus infeccioso | |
| NO984789L (no) | Midt-kjede forgrenede primµre alkylsulfater som surfaktanter | |
| BR0311132A (pt) | Inibidores do vìrus da hepatite c | |
| DK1781763T3 (da) | Fremgangsmåde for rengøring af industriudstyr med forbehandling | |
| BRPI0606858A2 (pt) | composições detergentes | |
| BRPI0414961A (pt) | processo de indução da diferenciação de células tronco em células do miocárdio | |
| CO5930056A1 (es) | Composiciones con ciclopopenos | |
| BRPI0417672A (pt) | processos para produzir composições de vìrus estáveis em armazenamento, composições de vìrus e imunogênicas | |
| BR0001399A (pt) | Processo para melhoria de estabilidade de viscosidade de uma composição aquosa, e composição | |
| BR9915728A (pt) | °ndice hidrofìlico para composições detergentes de lavanderia aquosas, lìquidas, contendo las | |
| BR0005488A (pt) | Processo para a preparação de carbonato de vinileno, e o uso do mesmo | |
| BR0113122A (pt) | Métodos para produzir reovìrus de mamìfero e reovìrus infeccioso, e, composição de reovìrus de mamìfero | |
| BR0116163A (pt) | Fotoiniciadores de superfìcie ativa | |
| BRPI0506462A (pt) | método de combustão de concentrado de rejeito orgánico | |
| BR0207988A (pt) | Cepas atenuadas vivas de vìrus de prrs | |
| AR069074A1 (es) | Modificacion de biosintesis de lignina por supresion con acido nucleico sentido | |
| WO2001083710A3 (en) | Clearance of neoplastic cells from mixed cellular compositions using viruses | |
| BR112013004470A2 (pt) | carvão de base celulósica termicamente ativado sorvente para remover mercúrio de emissões produzidas durante combustão de combustível e processo para aumentar a estabilidade térmica de carvão de base celulósica termicamente ativado | |
| BR0000041A (pt) | Processo para produzir ácido l-glutâmico | |
| BRPI0417894A (pt) | composição de barra | |
| BR0308736A (pt) | Células de pulmão de rato cotton para cultura de vìrus | |
| BR0312533A (pt) | Aparelho e processo para combinar duas ou mais correntes para redução de condensação em mistura de fluidos | |
| AR034084A1 (es) | Proceso para la remocion de dimetil eter en la sintesis de sevoflurano. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |